Insider · CIK 0001690298
Curran Terrie
director
Files at ARQT (Arcutis Biotherapeutics, Inc.). First filing Nov 13, 2024, latest Nov 13, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $94k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 50Moderate | sell 5 | ARQT Arcutis Biotherapeutics, Inc. | $94k | 8,687 | -46% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 11, 2024 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock | -8,687 | $10.85 | $94k | 10,139 | Nov 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.